Automated insulin delivery for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests a new automated insulin delivery system (APGO algorithm) to see how well it controls blood sugar and if it's safe. It may help people with type 1 diabetes manage their condition more easily.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 diabetes.
- You have had diabetes for at least 1 year.
- You are 18 years old or older.
- You are willing to follow the study rules and sign a consent form.
- You are not pregnant, breastfeeding, or planning to become pregnant.
- You are not taking any medicines that affect your body's sugar (carbohydrate) processing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
This trial is testing a new automated insulin pump system that talks to your smartphone and lets the care team check on you from home. It helps people with type 1 diabetes better manage their blood sugar without extra trips to the clinic.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
This study tests a new automated insulin delivery system (a pump that helps manage blood sugar) in children and adults with diabetes. It aims to see if the system is safe and easy to use in daily life.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
Hear when a new Diabetes Mellitus Type 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.